KIR3DL2 and myelodysplastic syndrome: The adoptive transfer of NK cells has shown impressive clinical results in patients with AML and myelodysplastic syndrome (MDS) in Killer-cell immunoglobulin-like receptor (KIR)-ligand mismatched settings [40,41,42,43].